These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32381748)

  • 61. Treatment of cognitive impairment in patients with multiple sclerosis.
    Patti F
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1679-99. PubMed ID: 22876911
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Aging with multiple sclerosis: prevalence and profile of cognitive impairment.
    Branco M; Ruano L; Portaccio E; Goretti B; Niccolai C; Patti F; Chisari C; Gallo P; Grossi P; Ghezzi A; Roscio M; Mattioli F; Bellomi F; Simone M; Viterbo RG; Amato MP
    Neurol Sci; 2019 Aug; 40(8):1651-1657. PubMed ID: 31011932
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Validity and sensitivity of Canadian normative data for the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) battery.
    Berard JA; Walker LAS
    Mult Scler Relat Disord; 2022 Jul; 63():103865. PubMed ID: 35580469
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gray matter networks and cognitive impairment in multiple sclerosis.
    Rimkus CM; Schoonheim MM; Steenwijk MD; Vrenken H; Eijlers AJ; Killestein J; Wattjes MP; Leite CC; Barkhof F; Tijms BM
    Mult Scler; 2019 Mar; 25(3):382-391. PubMed ID: 29320933
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Slowed articulation rate is associated with information processing speed decline in multiple sclerosis: A pilot study.
    Friedova L; Rusz J; Motyl J; Srpova B; Vodehnalova K; Andelova M; Novotna K; Novotny M; Ruzickova H; Tykalova T; Kubala Havrdova E; Horakova D; Uher T
    J Clin Neurosci; 2019 Jul; 65():28-33. PubMed ID: 31072740
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cognition in multiple sclerosis.
    Langdon DW
    Curr Opin Neurol; 2011 Jun; 24(3):244-9. PubMed ID: 21519256
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cognitive function in multiple sclerosis and its relation to functional abilities.
    Iwasaki Y; Kinoshita M; Ikeda K; Takamiya K
    Int J Neurosci; 1989 Oct; 48(3-4):219-23. PubMed ID: 2583936
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Turkish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery.
    Ozakbas S; Yigit P; Cinar BP; Limoncu H; Kahraman T; Kösehasanoğulları G
    BMC Neurol; 2017 Dec; 17(1):208. PubMed ID: 29207954
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management.
    Bagert B; Camplair P; Bourdette D
    CNS Drugs; 2002; 16(7):445-55. PubMed ID: 12056920
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
    Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
    J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis.
    Krupp LB; Sliwinski M; Masur DM; Friedberg F; Coyle PK
    Arch Neurol; 1994 Jul; 51(7):705-10. PubMed ID: 8018045
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cognition, cognitive dysfunction, and cognitive rehabilitation in multiple sclerosis.
    Pepping M; Brunings J; Goldberg M
    Phys Med Rehabil Clin N Am; 2013 Nov; 24(4):663-72. PubMed ID: 24314684
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The association between cognitive impairment and physical disability in multiple sclerosis.
    Lynch SG; Parmenter BA; Denney DR
    Mult Scler; 2005 Aug; 11(4):469-76. PubMed ID: 16042232
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Quality of life and cognitive functions in early onset multiple sclerosis.
    Lanzillo R; Chiodi A; Carotenuto A; Magri V; Napolitano A; Liuzzi R; Costabile T; Rainone N; Freda MF; Valerio P; Brescia Morra V
    Eur J Paediatr Neurol; 2016 Jan; 20(1):158-63. PubMed ID: 26387071
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [BCcogSEP: a French test battery evaluating cognitive functions in multiple sclerosis].
    Dujardin K; Sockeel P; Cabaret M; De Sèze J; Vermersch P
    Rev Neurol (Paris); 2004 Jan; 160(1):51-62. PubMed ID: 14978394
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of cognitive impairment in multiple sclerosis: position paper.
    Amato MP; Langdon D; Montalban X; Benedict RH; DeLuca J; Krupp LB; Thompson AJ; Comi G
    J Neurol; 2013 Jun; 260(6):1452-68. PubMed ID: 23180174
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cognitive dysfunction in different stages in multiple sclerosis--presentation of 3 cases.
    Faiss JH
    J Neurol; 2007 May; 254 Suppl 2():II77-9. PubMed ID: 17503135
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Managing cognitive impairment and its impact in multiple sclerosis: An Australian multidisciplinary perspective.
    Lechner-Scott J; Agland S; Allan M; Darby D; Diamond K; Merlo D; van der Walt A
    Mult Scler Relat Disord; 2023 Nov; 79():104952. PubMed ID: 37683558
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cognitive Impairment in Multiple Sclerosis.
    Trenova AG; Slavov GS; Manova MG; Aksentieva JB; Miteva LD; Stanilova SA
    Folia Med (Plovdiv); 2016 Sep; 58(3):157-163. PubMed ID: 27760012
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Do cardiovascular disease comorbidities affect the cognitive function of Multiple Sclerosis patients?
    Giannopapas V; Stavrogianni K; Christouli N; Kitsos D; Sideri E; Bakalidou D; Voumvourakis K; Papagiannopoulou G; Tzartos J; Paraskevas G; Tsivgoulis G; Giannopoulos S
    J Clin Neurosci; 2023 Jun; 112():20-24. PubMed ID: 37031630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.